MAIA MAIA Biotechnology, Inc.: institutional ownership and insider trading
37 funds reported holding $21.2M of MAIA Biotechnology, Inc. in their latest 13F filings; in Q2 2026 funds net bought $536K, with 13 new positions and 10 funds selling out; over the last 12 months insiders bought $986K and sold $0 on the open market.
Famous investors holding MAIA
- Renaissance Technologies (Renaissance Technologies): $599K, 0.0% of the portfolio
- Two Sigma (Two Sigma Investments): $72.6K, 0.0% of the portfolio
- Ken Griffin (Citadel Advisors): $35.8K, 0.0% of the portfolio
Largest institutional holders of MAIA
- Solas Capital Management, LLC — $4.36M
- Alyeska Investment Group, L.P. — $3.60M
- VANGUARD CAPITAL MANAGEMENT LLC — $3.48M
- VANGUARD GROUP INC — $1.77M
- 683 Capital Management, LLC — $1.54M
- Centric Wealth Management — $1.11M
- Cable Car Capital, LP — $741K
- GEODE CAPITAL MANAGEMENT, LLC — $727K
- Bleichroeder LP — $720K
- RENAISSANCE TECHNOLOGIES LLC — $599K
Recent MAIA insider trades
- Sep 14, 2026: Vitoc Vlad bought 73,000 shares ($100K)
- Sep 10, 2026: Guerrero Ramiro bought 37,595 shares ($49.6K)
- Aug 28, 2026: Guerrero Ramiro bought 133,790 shares ($184K)
- Aug 24, 2026: Guerrero Ramiro bought 1,794 shares ($2.39K)
5%+ owners
- FGMK Business Holdings, LLC: 10.0% (Schedule 13G, filed Mar 3, 2025)
- Vlad Vitoc: 9.7% (Schedule 13D/A, filed Dec 4, 2025)